AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.

Anhui Zhongsheng Traceability Biotechnology Co., Ltd., established on 2016-01-18, Business scope includes research and development of biological and medical technology products,manufacture,Production,storage,Applications and Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.

Jiusanjiheng Biomedical Technology Jiangsu Co., Ltd., established on 2016-05-30, The scope of business includes engaging in technology development in the field of biomedical technology,technical consulting,technology transfer;Bioelectronic Instruments and Equipment,Bioscience testing equipment,Laboratory analysis equipment,Technical development of electronic analysis and detection equipment,Production,Sales(Operating with a license involving medical devices);Application software development,Sales;Self-operated and agent import and export business of various commodities;Class III and Class II clinical laboratory analysis instruments,Development of in vitro diagnostic reagents.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Heze Stem Cell Technology Co., Ltd., established on 2010-08-23, Business scope includes life science technology development,Technology development and manufacture of stem cell engineering series products,Sales(Does not contain food,medicine,Health products);Industrialization of Stem Cell Series Technical Engineering Products;own property for rent;Research and development of related technologies for skin care products;Hair category,Skin care,Beauty Retouching,Perfume Cosmetics Production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

L’Oréal manufactures and sells cosmetic products for women and men worldwide. It offers skincare and haircare products, deodorants, make-up products, perfumes, oral cosmetics, hair colors, styling and shaping products, nail care products, and dermocosmetics. The company provides its products under the Lancôme, Giorgio Armani, Yves Saint Laurent Beauté, Biotherm, Kiehl’s, Ralph Lauren, Shu Uemura, Cacharel, Helena Rubinstein, Clarisonic, Diesel, Viktor&Rolf, Yue Sai, Maison Martin Margiela, Urban Decay, Guy Laroche, Paloma Picasso, Vichy, La Roche-Posay, SkinCeuticals, Roger&Gallet, Sanoflore, L’Oréal Paris, Garnier, Maybelline New York, Softsheen.Carson, Essie, L’Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Shu Uemura Art of Hair, Mizani, Essie, CARITA, and Decleor brand names.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments. Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.

AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology.

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Shenzhen Getaisaier Biotechnology Co., Ltd., established on 2018-01-29, Business scope includes general business items:Research and development of stem cell and tumor immune cell therapy technology,Application and promotion;Construction and investment of tissue cell bank;cell storage;Sales of electronic equipment;Biotechnology Services and Consulting;Research and development of bioengineering technology,technology transfer,technical consulting;biological reagent,R&D and sales of consumables and instruments(Does not contain drugs);medicine,Biological product,biomaterials,Biomedical,biohealth,Technology research and development of biological gene technology and products,technology transfer,technical consulting,Technical Services;Health management and health consulting services(Does not contain medical behavior);R & D and sales:cosmetic,skin care products,Health Supplies,Biological product,Class I medical device,Class II medical device.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:Sales of health products;production of cosmetics,skin care products,Health Supplies,Biological product,Class I medical device,Class II medical device.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).Research and development of bioengineering technology,Technology transfer,Technical Services;Biotechnology Consulting,Technical exchange service;research and development,Sales:biological reagent(Does not contain drugs and medical devices);medicine,Research and Development of Biomaterials,technical consulting,technology transfer,Technical Services;production of cosmetics;research and development,sell cosmetics;research and development,Production,Sales:Health Supplies,medical instruments(Class I medical device,Class II medical device);stem cell,Tumor immune cell technology research and development,technical consulting,technology transfer;Cell bank construction and investment;collection of stem cells,save,preparation service;Collection of immune cells,save,preparation service;Stem Cell Drug Development;Research and development of biomedical technology;Health Consulting Services;Medical institution project investment;Business Management Consulting;Sales of electronic equipment;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Shenzhen Jiyin Biotechnology Co., Ltd., established on 2021-07-07, Business scope includes general business items:R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;R&D of industrial enzyme preparations.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:none

Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bio-production. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bio-informatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world.

Beijing Beilai Biotechnology Co., Ltd., established on 2015-10-26, Business scope includes biotechnology development,technology transfer,technical consulting,Technical Services;Sales of daily necessities,cosmetic,Ι class medical device,Chemical Products,chemical reagent,plastic products,Glass product.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Guangzhou Meijian Biotechnology Co., Ltd., established on 2021-12-23, Business scope includes wholesale of cosmetics;Cosmetics Retail;General merchandise sales;Daily necessities wholesale;Daily necessities sales;Daily miscellaneous goods sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;R&D and application of cell technology;Human stem cell technology development and application;Personal Hygiene Sales;;

Huaxiayuan (Shanghai) Life Technology Co., Ltd., established on 2018-07-11, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Personal Hygiene Sales;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale),Cosmetic production(Limited to branch operations).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)